Understanding how proteins interact with DNA and RNA structures
Mechanisms and Specificity of Proteins that Manipulate DNA and RNA Structure
This study looks at how certain proteins interact with DNA and RNA to help our cells work properly, focusing on tools like CRISPR that can target specific sequences and how RNA helpers keep things from getting tangled, all to improve treatments for various health conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-11064005 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which proteins manipulate the structures of DNA and RNA, focusing on how these interactions can affect cellular processes. It explores the specificity of CRISPR-Cas enzymes in recognizing target sequences and the role of RNA chaperones in preventing misfolding. By examining the intrinsic properties of RNA and DNA, the research aims to enhance our understanding of how these molecules function and how their interactions can be optimized for therapeutic purposes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic disorders or cancers that may benefit from advanced gene editing technologies.
Not a fit: Patients with conditions unrelated to genetic mutations or those not amenable to gene therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved gene editing techniques and therapies for various diseases, including cancers.
How similar studies have performed: Previous research has shown promising results in enhancing the specificity and efficiency of CRISPR technologies, indicating that this approach has potential for significant advancements.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Russell, Rick — University of Texas at Austin
- Study coordinator: Russell, Rick
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.